Drugs / hMG-HP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT02785822 | Feb 2017 → May 2018 | polycystic ovary syndrome | Sant Pau Research Institute | Terminated | No outcome recorded Stop: Enrollment |
| Comparator or background therapy1 trial | ||||||
| — | NCT06103383 Background | Feb 2023 → Dec 2024 | female infertility | Instituto Valenciano de Infertilidad, IVI VALENCIA | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hMG-HP | “3 days stimullation protocol using hMG-HP” NCT06103383 ↗ |